Angitia Bio
6 known investors
Find your way into Angitia Bio
Sign up to see every warm intro you have to Angitia Bio
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Angitia Bio team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Angitia Bio is a biopharmaceutical company developing therapies for musculoskeletal and related diseases.
Investors · 6
OrbiMedlisted by OrbiMedNew York · $1M – $75M
How we know: OrbiMed's portfolio page · the VCSheet dataset · Not right? Tell us
FrazierreportedLehi
How we know: funding news · Not right? Tell us
Funding
SEC filings, press & company announcements- Undisclosed amountSeries DFeb 2026Source ↗
Source: company announcements and press reports — follow each round's link for the claim.
Frequently asked questions
- What does Angitia Bio do?
- Angitia Bio is a biopharmaceutical company developing therapies for musculoskeletal and related diseases.
- Who are Angitia Bio's investors?
- Angitia Bio's investors include Ascenta Capital, Frazier Life Sciences, OrbiMed, RA Capital, Wellington Management, Frazier.


